-
Publication Venue For
-
Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody Responses..
96:e0023122.
2022
-
Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on the Middle East respiratory syndrome coronavirus spike glycoprotein to avoid neutralization escape.
92.
2018
-
Interferon-Inducible CD169/Siglec1 Attenuates Anti-HIV-1 Effects of Alpha Interferon..
91:e00972-e00917.
2017
-
Caribbean and La Réunion Chikungunya Virus Isolates Differ in Their Capacity To Induce Proinflammatory Th1 and NK Cell Responses and Acute Joint Pathology..
89:7955-7969.
2015
-
Expanding regulatory T cells alleviates chikungunya virus-induced pathology in mice..
89:7893-7904.
2015
-
Particle-to-PFU Ratio of Ebola Virus Influences Disease Course and Survival in Cynomolgus Macaques.
89:6773-6781.
2015
-
Correction to Heavy Chain-Only IgG2b Llama antibody effects Near-Pan HIV-1 neutralization by recognizing a CD4-induced epitope that includes elements of coreceptor- and CD4-binding sites [Journal of Virology 87, 18, (2013) 10173-10181].
89:883-885.
2015
-
Spatial localization of the Ebola virus glycoprotein mucin-like domain determined by cryo-electron tomography..
88:10958-10962.
2014
-
CD4
+
T-Cell Help Enhances NK Cell Function following Therapeutic HIV-1 Vaccination.
88:8349-8354.
2014
-
Virus particle release from glycosphingolipid-enriched microdomains is essential for dendritic cell-mediated capture and transfer of HIV-1 and henipavirus..
88:8813-8825.
2014
-
HIV-1 envelope glycoprotein trimers display open quaternary conformation when bound to the gp41 membrane-proximal external-region-directed broadly neutralizing antibody Z13e1..
87:7191-7196.
2013
-
Utilization of Sialylated Glycans as Coreceptors Enhances the Neurovirulence of Serotype 3 Reovirus.
86:13164-13173.
2012
-
Longitudinal analysis of the human antibody response to Chikungunya virus infection: implications for serodiagnosis and vaccine development..
86:13005-13015.
2012
-
Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6..
86:6620-6631.
2012
-
The Reovirus σ1s Protein Is a Determinant of Hematogenous but Not Neural Virus Dissemination in Mice.
85:11781-11790.
2011
-
Characterization of glycosylation profiles of HIV-1 transmitted/founder envelopes by mass spectrometry.
85:8270-8284.
2011
-
Impact of HLA in mother and child on disease progression of pediatric human immunodeficiency virus type 1 infection..
83:10234-10244.
2009
-
Pharmacovirological impact of an integrase inhibitor on human immunodeficiency virus type 1 cDNA species in vivo..
83:7706-7717.
2009
-
Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants (Journal of Virology (2009) 83, 8, (3556-3567)).
83:6974.
2009
-
H5-type influenza virus hemagglutinin is functionally recognized by the natural killer-activating receptor NKp44..
82:2028-2032.
2008
-
Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles..
81:10869-10878.
2007
-
Induction of Antiviral Cytidine Deaminases Does Not Explain the Inhibition of Hepatitis B Virus Replication by Interferons.
81:10588-10596.
2007
-
Murine noroviruses comprising a single genogroup exhibit biological diversity despite limited sequence divergence..
81:10460-10473.
2007
-
Erratum: Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection (Journal of Virology (2006) 80, 22, (11094-11104)).
81:8846-8848.
2007
-
Genetic adaptation to untranslated region-mediated enterovirus growth deficits by mutations in the nonstructural proteins 3AB and 3CD..
81:8396-8405.
2007
-
Heterologous prime/boost immunization of rhesus monkeys by using diverse poxvirus vectors..
81:8563-8570.
2007
-
Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivo..
81:7540-7547.
2007
-
Generation of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzees..
81:7463-7475.
2007
-
Location and role of free cysteinyl residues in the Sindbis virus E1 and E2 glycoproteins..
81:6231-6240.
2007
-
The DNA binding domain of a papillomavirus E2 protein programs a chimeric nuclease to cleave integrated human papillomavirus DNA in HeLa cervical carcinoma cells..
81:6254-6264.
2007
-
Antiviral antibodies are necessary for control of simian immunodeficiency virus replication..
81:5024-5035.
2007
-
Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques..
81:5257-5269.
2007
-
A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques..
81:3414-3427.
2007
-
Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity..
81:3487-3494.
2007
-
Attenuation of herpes simplex virus neurovirulence with picornavirus cis-acting genetic elements..
81:791-799.
2007
-
Rapid memory CD8+ T-lymphocyte induction through priming with recombinant Mycobacterium smegmatis..
81:74-83.
2007
-
Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa..
80:11776-11790.
2006
-
Human immunodeficiency virus type 1 resistance to the small molecule maturation inhibitor 3-O-(3',3'-dimethylsuccinyl)-betulinic acid is conferred by a variety of single amino acid substitutions at the CA-SP1 cleavage site in Gag..
80:12095-12101.
2006
-
Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection..
80:11094-11104.
2006
-
Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes..
80:11393-11397.
2006
-
Adeno-associated virus type 2 contains an integrin alpha5beta1 binding domain essential for viral cell entry..
80:8961-8969.
2006
-
Integration Site Choice of a Feline Immunodeficiency Virus Vector.
80:8820-8823.
2006
-
Novel function of prothymosin alpha as a potent inhibitor of human immunodeficiency virus type 1 gene expression in primary macrophages..
80:9200-9206.
2006
-
Poxvirus tumor necrosis factor receptor (TNFR)-like T2 proteins contain a conserved preligand assembly domain that inhibits cellular TNFR1-induced cell death..
80:9300-9309.
2006
-
Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group m consensus env immunogen..
80:6745-6756.
2006
-
Structured treatment interruptions with tenofovir monotherapy for simian immunodeficiency virus-infected newborn macaques..
80:6399-6410.
2006
-
The double-stranded RNA binding protein 76:NF45 heterodimer inhibits translation initiation at the rhinovirus type 2 internal ribosome entry site..
80:6936-6942.
2006
-
Cell-type-specific repression of internal ribosome entry site activity by double-stranded RNA-binding protein 76..
80:3147-3156.
2006
-
Competitive translation efficiency at the picornavirus type 1 internal ribosome entry site facilitated by viral cis and trans factors..
80:3310-3321.
2006
-
Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels..
80:3732-3742.
2006
-
Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env..
80:1645-1652.
2006
-
A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease..
79:15356-15367.
2005
-
Induction of neutralizing antibodies against human immunodeficiency virus type 1 primary isolates by Gag-Env pseudovirion immunization..
79:14804-14814.
2005
-
Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages..
79:13250-13261.
2005
-
Effect of alternating passage on adaptation of sindbis virus to vertebrate and invertebrate cells..
79:14253-14260.
2005
-
Evaluation of envelope vaccines derived from the South African subtype C human immunodeficiency virus type 1 TV1 strain..
79:13338-13349.
2005
-
Human immunodeficiency virus type 1 subtype B ancestral envelope protein is functional and elicits neutralizing antibodies in rabbits similar to those elicited by a circulating subtype B envelope..
79:11214-11224.
2005
-
Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66..
79:11014-11021.
2005
-
Variation in interferon sensitivity and induction among strains of eastern equine encephalitis virus..
79:11300-11310.
2005
-
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies..
79:10108-10125.
2005
-
Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies..
79:10200-10209.
2005
-
DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge..
79:8480-8492.
2005
-
Effect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239delta3-vaccinated rhesus macaques..
79:8131-8141.
2005
-
Enhanced potency of plasmid DNA microparticle human immunodeficiency virus vaccines in rhesus macaques by using a priming-boosting regimen with recombinant proteins..
79:8189-8200.
2005
-
Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses..
79:8878-8885.
2005
-
Enhanced immunogenicity of gp120 protein when combined with recombinant DNA priming to generate antibodies that neutralize the JR-FL primary isolate of human immunodeficiency virus type 1..
79:7933-7937.
2005
-
Genetic determinants of cell type-specific poliovirus propagation in HEK 293 cells..
79:6281-6290.
2005
-
The polypyrimidine tract binding protein is required for efficient picornavirus gene expression and propagation..
79:6172-6179.
2005
-
Association of ebola virus matrix protein VP40 with microtubules..
79:4709-4719.
2005
-
Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression..
79:3350-3357.
2005
-
Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells..
79:3358-3369.
2005
-
Signature for long-term vaccine-mediated control of a Simian and human immunodeficiency virus 89.6P challenge: stable low-breadth and low-frequency T-cell response capable of coproducing gamma interferon and interleukin-2..
79:3243-3253.
2005
-
Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein..
79:1154-1163.
2005
-
Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins..
79:771-779.
2005
-
Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques..
79:955-965.
2005
-
Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus..
78:13819-13828.
2004
-
Gender differences in human immunodeficiency virus type 1-specific CD8 responses in the reproductive tract and colon following nasal peptide priming and modified vaccinia virus Ankara boosting..
78:13163-13172.
2004
-
Immunogenicity study of glycoprotein-deficient rabies virus expressing simian/human immunodeficiency virus SHIV89.6P envelope in a rhesus macaque..
78:13455-13459.
2004
-
Further investigation of simian immunodeficiency virus Vif function in human cells..
78:12041-12046.
2004
-
Impact on genetic networks in human macrophages by a CCR5 strain of human immunodeficiency virus type 1..
78:11477-11486.
2004
-
Genetic relationships and evolution of genotypes of yellow fever virus and other members of the yellow fever virus group within the Flavivirus genus based on the 3' noncoding region..
78:9652-9665.
2004
-
Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody..
78:9233-9242.
2004
-
Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys..
78:7490-7497.
2004
-
New simian immunodeficiency virus infecting De Brazza's monkeys (Cercopithecus neglectus): evidence for a cercopithecus monkey virus clade..
78:7748-7762.
2004
-
Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies..
78:5983-5995.
2004
-
Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups..
78:4421-4432.
2004
-
Immunogenicity of constrained monoclonal antibody A32-human immunodeficiency virus (HIV) Env gp120 complexes compared to that of recombinant HIV type 1 gp120 envelope glycoproteins..
78:5270-5278.
2004
-
Inability of Simian Virus 40 To Establish Productive Infection of Lymphoblastic Cell Lines.
78:4917-4920.
2004
-
Correlation between env V1/V2 region diversification and neutralizing antibodies during primary infection by simian immunodeficiency virus sm in rhesus macaques..
78:3561-3571.
2004
-
Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol..
78:3930-3940.
2004
-
Repression of the human papillomavirus E6 gene initiates p53-dependent, telomerase-independent senescence and apoptosis in HeLa cervical carcinoma cells..
78:4063-4073.
2004
-
Unselected mutations in the human immunodeficiency virus type 1 genome are mostly nonsynonymous and often deleterious..
78:2426-2433.
2004
-
Immune failure in the absence of profound CD4+ T-lymphocyte depletion in simian immunodeficiency virus-infected rapid progressor macaques..
78:275-284.
2004
-
Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation..
78:922-929.
2004
-
Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239..
77:13348-13360.
2003
-
Structure and function of CC-chemokine receptor 5 homologues derived from representative primate species and subspecies of the taxonomic suborders Prosimii and Anthropoidea..
77:12310-12318.
2003
-
Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies..
77:10348-10356.
2003
-
Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3' proximal genome positions of bovine/human parainfluenza virus type 3 on virus replication and immunogenicity..
77:10819-10828.
2003
-
Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate..
77:11244-11259.
2003
-
Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen..
77:8354-8365.
2003
-
Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses..
77:9029-9040.
2003
-
Foci of endemic simian immunodeficiency virus infection in wild-living eastern chimpanzees (Pan troglodytes schweinfurthii)..
77:7545-7562.
2003
-
CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition..
77:6777-6784.
2003
-
Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene..
77:6743-6752.
2003
-
RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells..
77:6066-6069.
2003
-
Loss of the perforin cytotoxic pathway predisposes mice to experimental cytomegalovirus retinitis..
77:3402-3408.
2003
-
Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses..
77:3099-3118.
2003
-
Amplification of a complete simian immunodeficiency virus genome from fecal RNA of a wild chimpanzee..
77:2233-2242.
2003
-
Effect of humoral immune responses on controlling viremia during primary infection of rhesus monkeys with simian immunodeficiency virus..
77:2165-2173.
2003
-
Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d..
77:2046-2055.
2003
-
Phosphatidylinositol 3-kinase regulates human immunodeficiency virus type 1 replication following viral entry in primary CD4+ T lymphocytes and macrophages..
77:2539-2549.
2003
-
Glycosaminoglycan binding properties of natural venezuelan equine encephalitis virus isolates..
77:1204-1210.
2003
-
Marker rescue of adeno-associated virus (AAV) capsid mutants: a novel approach for chimeric AAV production..
77:423-432.
2003
-
Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine..
77:1049-1058.
2003
-
Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes..
77:546-559.
2003
-
Identification of the orthopoxvirus p4c gene, which encodes a structural protein that directs intracellular mature virus particles into A-type inclusions..
76:11216-11225.
2002
-
Live, attenuated simian immunodeficiency virus SIVmac-M4, with point mutations in the Env transmembrane protein intracytoplasmic domain, provides partial protection from mucosal challenge with pathogenic SIVmac251..
76:11365-11378.
2002
-
Mandelic acid condensation polymer: novel candidate microbicide for prevention of human immunodeficiency virus and herpes simplex virus entry..
76:11236-11244.
2002
-
Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection..
76:10507-10511.
2002
-
Elevated chemokine responses are maintained in lungs after clearance of viral infection..
76:10518-10523.
2002
-
In Vivo Gene Transfer Using a Nonprimate Lentiviral Vector Pseudotyped with Ross River Virus Glycoproteins.
76:9378-9388.
2002
-
Generation of neutralizing activity against human immunodeficiency virus type 1 in serum by antibody gene transfer..
76:8769-8775.
2002
-
Genetically stable picornavirus expression vectors with recombinant internal ribosomal entry sites..
76:8966-8972.
2002
-
Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines..
76:7625-7631.
2002
-
Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1..
76:8276-8284.
2002
-
Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239..
76:7187-7202.
2002
-
Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine..
76:6138-6146.
2002
-
Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization..
76:5357-5368.
2002
-
Molecular evolution of human immunodeficiency virus env in humans and monkeys: similar patterns occur during natural disease progression or rapid virus passage..
76:5278-5284.
2002
-
Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa..
76:2233-2244.
2002
-
A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation..
76:569-581.
2002
-
ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency..
76:292-302.
2002
-
Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization..
76:517-524.
2002
-
Molecular epidemiology of human immunodeficiency virus type 1 transmission in a heterosexual cohort of discordant couples in Zambia..
76:397-405.
2002
-
Rev-independent simian immunodeficiency virus strains are nonpathogenic in neonatal macaques..
76:96-104.
2002
-
NF-kappaB cis-acting motifs of the human immunodeficiency virus (HIV) long terminal repeat regulate HIV transcription in human macrophages..
75:11408-11416.
2001
-
Neutralizing antibodies associated with viremia control in a subset of individuals after treatment of acute human immunodeficiency virus type 1 infection..
75:10200-10207.
2001
-
Jaagsiekte Sheep Retrovirus Env Protein Stabilizes Retrovirus Vectors against Inactivation by Lung Surfactant, Centrifugation, and Freeze-Thaw Cycling.
75:8864-8867.
2001
-
Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines..
75:8681-8689.
2001
-
Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors..
75:7266-7279.
2001
-
Molecular basis for cell tropism of CXCR4-dependent human immunodeficiency virus type 1 isolates..
75:6776-6785.
2001
-
Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge..
75:7470-7480.
2001
-
Wild Mandrillus sphinx are carriers of two types of lentivirus..
75:7086-7096.
2001
-
Induction and characterization of neutralizing antibodies against a human immunodeficiency virus type 1 primary isolate..
75:6700-6704.
2001
-
Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaques..
75:5879-5890.
2001
-
Potential sources of the 1995 Venezuelan equine encephalitis subtype IC epidemic..
75:5823-5832.
2001
-
Human cytomegalovirus US2 endoplasmic reticulum-lumenal domain dictates association with major histocompatibility complex class I in a locus-specific manner..
75:5197-5204.
2001
-
Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination..
75:5151-5158.
2001
-
Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein..
75:5230-5239.
2001
-
Characterization of human immunodeficiency virus type 1 in saliva and blood plasma by V3-specific heteroduplex tracking assay and genotype analyses..
75:4936-4940.
2001
-
Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and control of a simian-human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelope..
75:4165-4175.
2001
-
Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate..
75:3568-3580.
2001
-
RNA replication from the simian virus 5 antigenomic promoter requires three sequence-dependent elements separated by sequence-independent spacer regions..
75:3993-3998.
2001
-
Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques..
75:2224-2234.
2001
-
Functional analysis of the simian immunodeficiency virus Vpx protein: identification of packaging determinants and a novel nuclear targeting domain..
75:362-374.
2001
-
Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140..
75:645-653.
2001
-
In vivo attenuation of simian immunodeficiency virus by disruption of a tyrosine-dependent sorting signal in the envelope glycoprotein cytoplasmic tail..
75:278-291.
2001
-
A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant..
74:11286-11295.
2000
-
Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virions..
74:10514-10522.
2000
-
Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen..
74:8946-8952.
2000
-
Identification of gp120 regions targeted by a highly potent neutralizing antiserum elicited in a chimpanzee inoculated with a primary human immunodeficiency virus type 1 isolate..
74:9749-9754.
2000
-
Overexpression of p21(waf1) in human T-cell lymphotropic virus type 1-infected cells and its association with cyclin A/cdk2..
74:7270-7283.
2000
-
Loss of G(1)/S checkpoint in human immunodeficiency virus type 1-infected cells is associated with a lack of cyclin-dependent kinase inhibitor p21/Waf1..
74:5040-5052.
2000
-
Clinical isolates of measles virus use CD46 as a cellular receptor..
74:3967-3974.
2000
-
Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses..
74:3227-3234.
2000
-
Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques..
74:2960-2965.
2000
-
Characterization of the trans-activation properties of equine herpesvirus 1 EICP0 protein..
74:1200-1208.
2000
-
Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strains..
74:254-263.
2000
-
Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles..
74:371-378.
2000
-
Characterization of primary isolate-like variants of simian-human immunodeficiency virus..
73:10199-10207.
1999
-
Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity..
73:10310-10319.
1999
-
Protection by live, attenuated simian immunodeficiency virus against heterologous challenge..
73:8356-8363.
1999
-
Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in Macaques..
73:8201-8215.
1999
-
Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection..
73:5509-5519.
1999
-
Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation..
73:4952-4961.
1999
-
Genetic and phenotypic changes accompanying the emergence of epizootic subtype IC Venezuelan equine encephalitis viruses from an enzootic subtype ID progenitor..
73:4266-4271.
1999
-
Protection of macaques against intrarectal infection by a combination immunization regimen with recombinant simian immunodeficiency virus SIVmne gp160 vaccines..
73:3134-3146.
1999
-
Residues critical for duck hepatitis B virus neutralization are involved in host cell interaction..
73:2569-2575.
1999
-
Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence..
73:958-964.
1999
-
Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen..
73:618-630.
1999
-
Nuclear magnetic resonance analysis of solution conformations in C4-V3 hybrid peptides derived from human immunodeficiency virus (HIV) type 1 gp120: relation to specificity of peptide-induced anti-HIV neutralizing antibodies..
73:746-750.
1999
-
RNA replication for the paramyxovirus simian virus 5 requires an internal repeated (CGNNNN) sequence motif..
73:805-809.
1999
-
An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I)..
72:10234-10241.
1998
-
Localization of a baculovirus-induced chitinase in the insect cell endoplasmic reticulum..
72:10207-10212.
1998
-
A small yeast RNA blocks hepatitis C virus internal ribosome entry site (HCV IRES)-mediated translation and inhibits replication of a chimeric poliovirus under translational control of the HCV IRES element (vol 72, pg 5638, 1998).
72:9419-9419.
1998
-
Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting..
72:9092-9100.
1998
-
Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine..
72:7501-7509.
1998
-
Neutralizing antibodies in sera from macaques immunized with attenuated simian immunodeficiency virus..
72:6950-6955.
1998
-
Viral genetic evolution in macaques infected with molecularly cloned simian immunodeficiency virus correlates with the extent of persistent viremia..
72:6482-6489.
1998
-
A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1..
72:5680-5698.
1998
-
A small yeast RNA blocks hepatitis C virus internal ribosome entry site (HCV IRES)-mediated translation and inhibits replication of a chimeric poliovirus under translational control of the HCV IRES element..
72:5638-5647.
1998
-
Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry..
72:5425-5432.
1998
-
Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1..
72:4962-4969.
1998
-
Mechanism of injury-provoked poliomyelitis..
72:5056-5060.
1998
-
Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure..
72:4170-4182.
1998
-
CBF, Myb, and Ets binding sites are important for activity of the core I element of the murine retrovirus SL3-3 in T lymphocytes..
72:3129-3137.
1998
-
Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1..
72:3427-3431.
1998
-
Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage..
72:1886-1893.
1998
-
Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines..
72:1552-1576.
1998
-
Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted..
72:926-933.
1998
-
A functional antigenomic promoter for the paramyxovirus simian virus 5 requires proper spacing between an essential internal segment and the 3' terminus..
72:10-19.
1998
-
Erratum: A small yeast RNA blocks hepatitis C virus internal ribosome entry site (HCV IRES)-mediated translation and inhibits replication of a chimeric poliovirus under translational control of the HCV IRES element (Journal of Virology (1998) 72:7 (5638-5647)).
72:9419.
1998
-
Natural infection of a household pet red-capped mangabey (Cercocebus torquatus torquatus) with a new simian immunodeficiency virus..
72:600-608.
1998
-
Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaque..
72:585-592.
1998
-
Transgenic plants expressing potato virus X ORF2 protein (p24) are resistant to tobacco mosaic virus and Ob tobamoviruses..
72:731-738.
1998
-
Rotavirus RNA polymerase requires the core shell protein to synthesize the double-stranded RNA genome..
71:9618-9626.
1997
-
Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians..
71:8908-8911.
1997
-
Molecular analysis of the feline immunodeficiency virus protease: generation of a novel form of the protease by autoproteolysis and construction of cleavage-resistant proteases..
71:5505-5511.
1997
-
The ICP0 protein of equine herpesvirus 1 is an early protein that independently transactivates expression of all classes of viral promoters..
71:4904-4914.
1997
-
Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple..
71:2647-2655.
1997
-
Antibody-mediated neutralization of primary isolates of human immunodeficiency virus type 1 in peripheral blood mononuclear cells is not affected by the initial activation state of the cells..
71:2512-2517.
1997
-
A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3..
71:1608-1620.
1997
-
Importance of a c-Myb binding site for lymphomagenesis by the retrovirus SL3-3..
71:1213-1219.
1997
-
Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: effects of viral variation on cytotoxic T-lymphocyte recognition..
71:1256-1264.
1997
-
The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin..
70:7013-7029.
1996
-
Increased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses..
70:6136-6142.
1996
-
Inhibition of nitric oxide synthesis increases mortality in Sindbis virus encephalitis..
70:3972-3977.
1996
-
Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara..
70:3741-3752.
1996
-
Simian immunodeficiency virus DNA vaccine trial in macaques..
70:3978-3991.
1996
-
Vaccine protection by a triple deletion mutant of simian immunodeficiency virus..
70:3724-3733.
1996
-
An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys..
70:3198-3206.
1996
-
n-Butyrate, a cell cycle blocker, inhibits early amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of duck hepatocytes..
70:2691-2696.
1996
-
Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization..
70:1651-1667.
1996
-
Sequences within a small yeast RNA required for inhibition of internal initiation of translation: interaction with La and other cellular proteins influences its inhibitory activity..
70:1624-1632.
1996
-
Sequences flanking the pentanucleotide T-antigen binding sites in the polyomavirus core origin help determine selectivity of DNA replication..
69:7570-7578.
1995
-
Immunogenic determinants of a neuropathogenic murine leukemia virus..
69:6847-6851.
1995
-
Potent inhibition of human immunodeficiency virus type 1 (HIV-1) replication by inducible expression of HIV-1 PR multimers..
69:5988-5994.
1995
-
Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1..
69:6239-6248.
1995
-
A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells..
69:5217-5227.
1995
-
Phenotypic and genotypic characteristics of human immunodeficiency virus type 1 from patients with AIDS in northern Thailand..
69:4649-4655.
1995
-
Cellular CD44S as a determinant of human immunodeficiency virus type 1 infection and cellular tropism..
69:4000-4005.
1995
-
A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion..
69:3771-3777.
1995
-
Direct interactions between autoantigen La and human immunodeficiency virus leader RNA..
69:618-619.
1995
-
Direct interactions between autoantigen La and human immunodeficiency virus leader RNA..
68:7008-7020.
1994
-
Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology..
68:7433-7447.
1994
-
Transcription factor AP-2 regulates human immunodeficiency virus type 1 gene expression..
68:6820-6823.
1994
-
Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect rhesus monkeys from SIV experimental challenge..
68:6578-6588.
1994
-
Biological, molecular, and structural analysis of a cytopathic variant from a molecularly cloned simian immunodeficiency virus..
68:5509-5522.
1994
-
Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins..
68:5685-5689.
1994
-
Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes..
68:3410-3414.
1994
-
Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques..
68:2362-2370.
1994
-
Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein..
68:2624-2631.
1994
-
T-antigen kinase inhibits simian virus 40 DNA replication by phosphorylation of intact T antigen on serines 120 and 123..
68:269-275.
1994
-
Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive element..
67:6882-6888.
1993
-
Phenotypic and functional consequences of herpesvirus saimiri infection of human CD8+ cytotoxic T lymphocytes..
67:6317-6321.
1993
-
Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivo..
67:3951-3960.
1993
-
Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells..
67:4062-4069.
1993
-
La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate..
67:3798-3807.
1993
-
Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein..
67:3615-3619.
1993
-
Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21)..
67:2699-2706.
1993
-
Recognition by and in vitro induction of cytotoxic T lymphocytes against predicted epitopes of the immediate-early protein ICP27 of herpes simplex virus..
67:613-616.
1993
-
Plasmid models for bacteriophage T4 DNA replication: requirements for fork proteins..
66:6960-6968.
1992
-
Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins..
66:5879-5889.
1992
-
In vivo genetic variability of the human immunodeficiency virus type 2 V3 region..
66:4546-4550.
1992
-
The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro..
66:4085-4097.
1992
-
Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types..
66:3971-3975.
1992
-
Mutational analysis of conserved N-linked glycosylation sites of human immunodeficiency virus type 1 gp41..
66:1799-1803.
1992
-
Analysis of trans activation by human papillomavirus type 16 E7 and adenovirus 12S E1A suggests a common mechanism..
65:6922-6930.
1991
-
Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation..
65:6811-6816.
1991
-
Anti-glycoprotein D monoclonal antibody protects against herpes simplex virus type 1-induced diseases in mice functionally depleted of selected T-cell subsets or asialo GM1+ cells..
65:6008-6014.
1991
-
Role of conserved gp41 cysteine residues in the processing of human immunodeficiency virus envelope precursor and viral infectivity..
65:6349-6352.
1991
-
Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophages..
65:4309-4316.
1991
-
Protein phosphatase 2A dephosphorylates simian virus 40 large T antigen specifically at residues involved in regulation of DNA-binding activity..
65:2098-2101.
1991
-
Complement-mediated, infection-enhancing antibodies in plasma from vaccinated macaques before and after inoculation with live simian immunodeficiency virus..
64:5223-5225.
1990
-
Kinetics of poliovirus uncoating in HeLa cells in a nonacidic environment..
64:3590-3597.
1990
-
Translation by the adenovirus tripartite leader: elements which determine independence from cap-binding protein complex..
64:2669-2677.
1990
-
Association of p62c-yes with polyomavirus middle T-antigen mutants correlates with transforming ability..
64:1584-1589.
1990
-
Antibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus macaques..
64:113-119.
1990
-
Structure and orientation of expressed bovine coronavirus hemagglutinin-esterase protein.
64:1834-1838.
1990
-
Requirements for species-specific papovavirus DNA replication.
63:5371-5385.
1989
-
Transcription of a poxvirus early gene is regulated both by a short promoter element and by a transcriptional termination signal controlling transcriptional interference..
63:4632-4644.
1989
-
Viral transcription is necessary and sufficient for vesicular stomatitis virus to inhibit maturation of small nuclear ribonucleoproteins..
63:4172-4180.
1989
-
Development and characterization of an Fv-1-sensitive retrovirus-packaging system: single-hit titration kinetics observed in restrictive cells..
63:2592-2597.
1989
-
The second-largest subunit of the poxvirus RNA polymerase is similar to the corresponding subunits of procaryotic and eucaryotic RNA polymerases..
63:1076-1086.
1989
-
Cellular gene expression in papillomas of the choroid plexus from transgenic mice that express the simian virus 40 large T antigen..
63:790-797.
1989
-
Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4..
62:4195-4200.
1988
-
Simian virus 40 (SV40) T antigen binds specifically to double-stranded DNA but not to single-stranded DNA or DNA/RNA hybrids containing the SV40 regulatory sequences..
62:2204-2208.
1988
-
Retroviral vector gene expression in F9 embryonal carcinoma cells..
61:3248-3253.
1987
-
Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection..
61:2017-2023.
1987
-
Relationship between simian virus 40 large tumor antigen expression and tumor formation in transgenic mice..
61:2029-2032.
1987
-
Nucleic acid sequence and oncogenic properties of the HZ2 feline sarcoma virus v-abl insert..
61:1193-1202.
1987
-
Lack of evidence for VPg priming of poliovirus RNA synthesis in the host factor-dependent in vitro replicase reaction..
58:212-215.
1986
-
Fusion of the termini of the murine cytomegalovirus genome after infection..
52:24-28.
1984
-
Sites of copy choice replication involved in generation of vesicular stomatitis virus defective-interfering particle RNAs..
51:515-521.
1984
-
Nucleotide sequence and host La protein interactions of rabies virus leader RNA..
50:773-778.
1984
-
Revertants and partial transformants of rat fibroblasts infected with Fujinami sarcoma virus..
50:325-334.
1984
-
Cytoplasmic localization of the transforming protein of Fujinami sarcoma virus: salt-sensitive association with subcellular components..
45:782-791.
1983
-
RNA polymerase-associated interactions near template promoter sequences of defective interfering particles of vesicular stomatitis virus..
43:241-249.
1982
-
Polyoma virus infection of retinoic acid-induced differentiated teratocarcinoma cells..
39:306-312.
1981
-
Mutants of Fujinami sarcoma virus which are temperature sensitive for cellular transformation and protein kinase activity..
38:347-355.
1981
-
Simian virus 40 transcriptional complexes incorporate mercurated nucleotides into RNA in vitro..
37:511-517.
1981
-
Site on the vesicular stomatitis virus genome specifying polyadenylation and the end of the L gene mRNA..
34:550-559.
1980
-
Intervening sequence between the leader region and the nucleopcapsid gene of vesicular stomatitis virus RNA..
33:789-794.
1980
-
Terminal sequences of vesicular stomatitis virus RNA are both complementary and conserved..
32:167-174.
1979
-
Topography of a flexible ribonucleoprotein helix: protein-protein contacts in Sendai virus nucleocapsids..
30:701-710.
1979
-
Evidence that a precursor glycoprotein is cleaved to yield the major glycoprotein of avian tumor virus..
21:810-814.
1977
-
Interspecies determinants of Friend leukemia virus antigens involved in cytolysis of virus-pfoducing cells..
21:113-118.
1977
-
Role of carbohydrate in biological functions of Friend murine leukemia virus gp71..
21:35-40.
1977
-
Viral glycoprotein synthesis studies in an established line of Japanese quail embryo cells infected with the Bryan high-titer strain of Rous sarcoma virus..
18:504-510.
1976
-
Purification and serological characterization of the major envelope glycoprotein from AKR murine leukemia virus and its reactivity with autogenous immune sera from mice..
17:727-736.
1976
-
Role of carbohydrate in determining the immunochemical properties of the major glycoprotein (gp71) of Friend murine leukemia virus..
16:1453-1463.
1975
-
Mitosis is required for production of murine leukemia virus and structural proteins during de novo infection..
16:267-274.
1975
-
Expression of the Major Viral Glycoprotein of Avian Tumor Virus in Cells of chf(+) Chicken Embryos..
15:1131-1140.
1975
-
Isolation of two subgroup-specific leukemogenic viruses from standard avian myeloblastosis virus..
15:906-912.
1975
-
Reactivity of avian RNA tumor viruses with lectins..
17:132-139.
1975
-
Outer membrane of avian myeloblastosis virus..
12:1579-1588.
1973
-
Multiple and specific initiation of T4 DNA replication..
12:130-148.
1973
-
Early intracellular events in the replication of bacteriophage T4 deoxyribonucleic acid. VI. Newly synthesized proteins in the T4 protein-deoxyribonucleic acid complex..
5:502-506.
1970
-
In vitro chick embryo cell response to strain MC29 avian leukosis virus..
2:576-586.
1968
-
Erratum to Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies [Journal of Virology, 85, 21, (2011) 11401-11408] DOI: 10.1128/JVI.05312-11.
87:13936.
2013
-
Neutralization-sensitive R5-tropic simian-human immunodeficiency virus SHIV-2873Nip, which carries env isolated from an infant with a recent HIV clade C infection (Journal of Virology (2009) 83, 3, (1422-1432)).
83:8297.
2009
-
Partial protection of simian immunodeficiency virus (SIV)-infected rhesus monkeys against superinfection with a heterologous SIV isolate (Journal of Virology (2009) 83, 6 (2686-2696)).
83:5293.
2009
-
Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines..
79:10103-10107.
2005
-
Erratum: Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles (Journal of Virology (2000) 74:1 (371-378)).
74:3430.
2000